Tianyin Pharmaceutical CO (TPIY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2011 | 03-2011 | 12-2010 | 09-2010 | 06-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,623 | 13,401 | 9,344 | 3,397 | 11,898 |
| Depreciation Amortization | 1,188 | 894 | 603 | 314 | 954 |
| Accounts receivable | -497 | -1,236 | -949 | -843 | -2,770 |
| Accounts payable and accrued liabilities | -525 | 280 | -170 | -1,140 | 2,239 |
| Other Working Capital | -2,977 | -2,376 | 340 | -3,707 | 1,067 |
| Other Operating Activity | 1,375 | 1,242 | 1,600 | 3,525 | 2,012 |
| Operating Cash Flow | $14,186 | $12,205 | $10,766 | $1,546 | $15,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,018 | -10,318 | -7,401 | -1,923 | -5,809 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -2,743 |
| Other Investing Activity | 302 | 300 | 298 | 0 | -3,036 |
| Investing Cash Flow | $-11,716 | $-10,018 | $-7,102 | $-1,923 | $-8,845 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,209 | 1,201 | N/A | N/A | 66 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 8,895 |
| Dividend Paid | -143 | -55 | -55 | -55 | -1,409 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 440 |
| Financing Cash Flow | $1,066 | $1,146 | $-55 | $-55 | $7,992 |
| Exchange Rate Effect | 1,179 | 724 | 551 | 312 | 110 |
| Beginning Cash Position | 27,009 | 27,009 | 27,009 | 27,009 | 12,352 |
| End Cash Position | 31,725 | 31,067 | 31,169 | 26,889 | 27,009 |
| Net Cash Flow | $4,716 | $4,058 | $4,160 | $-120 | $14,657 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,186 | 12,205 | 10,766 | 1,546 | 15,400 |
| Capital Expenditure | -12,018 | -10,318 | -7,401 | -1,923 | -5,809 |
| Free Cash Flow | 2,168 | 1,887 | 3,366 | -377 | 9,591 |